Clopidogrel Bisulphate
Generic Name: clopidogrel bisulphate
Dosage form: POWDER. Active ingredients: CLOPIDOGREL BISULFATE (1 kg/kg). Category: BULK INGREDIENT.
Overview
Dosage form: POWDER. Active ingredients: CLOPIDOGREL BISULFATE (1 kg/kg). Category: BULK INGREDIENT.
Dosage
Available as powder.
Related Medications
Conium Maculatum, Abies Canadensis, Tulip Gesneriana, Oleander, American Elm, Plane (sycamore), Ash, Beech, Willow, Elder (box Elder), Alder, Cedar, Maple, Hazel, Poplar, Silver Birch, Oak, Hickory, Arsenicum Album, Lycopodium Clavatum, Pulsatilla (pratensis), Magnolia Grandiflora, Myrica Cerifers, Lilac (syringa Vulgaris)
conium maculatum, abies canadensis, tulip gesneriana, oleander, american elm, plane (sycamore), ash, beech, willow, elder (box elder), alder, cedar, maple, hazel, poplar, silver birch, oak, hickory, arsenicum album, lycopodium clavatum, pulsatilla (pratensis), magnolia grandiflora, myrica cerifers, lilac (syringa vulgaris)
Non-Standardized Pollen Allergenic Extract [EPC]
INDICATIONS: May temporarily relieve symptoms associated with tree sensitivities, such as congestion and runny nose and sneezing.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evalutated.
Alfalfa, Calcarea Phosphorica, Chamomilla, Eschscholtzia Californica, Melissa Officinalis, Passiflora Incarnata, Pulsatilla, Scutellaria Lateriflora, Valeriana Officinalis
alfalfa, calcarea phosphorica, chamomilla, eschscholtzia californica, melissa officinalis, passiflora incarnata, pulsatilla, scutellaria lateriflora, valeriana officinalis
Purpose restless sleep frequent waking inability to fall asleep sleeplessness restless sleep sleeplessness from restlessness, worries and exhaustion frequent waking sleeplessness from nervousness and excitability restless sleep
Coxsackie Nosode A2, A7, B1, B3, B5
coxsackie nosode a2, a7, b1, b3, b5
Dosage form: LIQUID. Active ingredients: HUMAN COXSACKIEVIRUS A2 (60 [hp_C]/mL); HUMAN COXSACKIEVIRUS A7 (60 [hp_C]/mL); HUMAN COXSACKIEVIRUS B1 (60 [hp_C]/mL); HUMAN COXSACKIEVIRUS B3 (60 [hp_C]/mL); HUMAN COXSACKIEVIRUS B5 (60 [hp_C]/mL). Category: DRUG FOR FURTHER PROCESSING.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.